| 000 | 01780 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516001611.0 | ||
| 264 | 0 | _c20110310 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1873-4995 | ||
| 024 | 7 |
_a10.1016/j.jconrel.2010.08.030 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHaber, E | |
| 245 | 0 | 0 |
_aRoute of administration-dependent anti-inflammatory effect of liposomal alendronate. _h[electronic resource] |
| 260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cDec 2010 |
||
| 300 |
_a226-33 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlendronate _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCarotid Stenosis _xblood |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 |
_aEndometriosis _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aLiposomes |
| 650 | 0 | 4 |
_aMacrophages, Peritoneal _xdrug effects |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aAfergan, E | |
| 700 | 1 | _aEpstein, H | |
| 700 | 1 | _aGutman, D | |
| 700 | 1 | _aKoroukhov, N | |
| 700 | 1 | _aBen-David, M | |
| 700 | 1 | _aSchachter, M | |
| 700 | 1 | _aGolomb, G | |
| 773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 148 _gno. 2 _gp. 226-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jconrel.2010.08.030 _zAvailable from publisher's website |
| 999 |
_c20146167 _d20146167 |
||